Article Abstract

Immunotherapeutic strategies in patients with advanced head and neck squamous cell carcinoma

Authors: Maysaloun Merhi, Afsheen Raza, Varghese Inchakalody, Abdul Rahman Zar, Shahab Uddin, Said Dermime


Most head and neck squamous cell carcinoma (HNSCC) patients present with advanced-stage disease often with significant rates of local failure and distant metastases (1). Over the past two decades, the survival rates of HNSCC patients have not been altered significantly by standard therapy (2).

Article Options

Download Citation